Recent developments of interest in cardiovascular medicine
— Recent developments of interest in cardiovascular medicine
by Nicole Lou, Senior Staff Writer, MedPage Today
May 19, 2026
• 2 min read
In primary care, a first prescription for high blood pressure (BP) could be tied to a small increased risk of hospitalization or death due to a fall, according to a retrospective observational analysis. (Lancet Primary Care)
Since the introduction of durable left ventricular assist devices for advanced heart failure, management of antithrombotic…
Non-steroidal anti-inflammatory drugs like ibuprofen, naproxen, and diclofenac can elevate blood pressure and damage blood…
ORLANDO — Ralinepag, a prostacyclin receptor agonist, added to background therapy decreased the risk for a clinical worsening…
Also in TTHealthWatch: digoxin for heart failure
Digitalis glycosides may be a safe and tolerable addition to optimal guideline medical therapy to reduce worsening heart failure…
WASHINGTON — GLP-1 receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide agonists are not likely to…
Rapid evolution of antithrombotic therapy in the HeartMate3 era: What you should know
Add-on ralinepag delays first clinical worsening event in PAH
Digitalis glycosides could safely prevent worsening heart failure events
Pharmacology Consult | Cardiology | Healio
Three years of declining overdose deaths begets cautious optimism and some concerns
'Huge step forward': Ozempic endorsed to treat obesity and heart disease in Australian first
Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug
Opinion | What older adults should know about risky prescription drugs
FDA floats possible approach to repurpose approved drugs under new uses
